To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.

Inclusion Criteria: 1. Liver cirrhosis (Child B or Child C class) 2. Age between 18-60 years 3. History of recovery from episodeof overt hepatic encephalopathy (West-Haven grade 1 and above) in last 12 months. Exclusion Criteria: 1. Evidence of overt hepatic encephalopathy at the time of enrollment 2. History of taking lactulose, rifaximin, neomycin, metronidazole, L-Ornithine L-Aspartate or probiotics in past 7 days 3. Alcohol intake during past 6 weeks 4. Receiving secondary prophylaxis for spontaneous bacterial peritonitis 5. Previous transjugular intrahepatic portosystemic shunts or shunt surgery 6. Significant comorbid illness such as heart, respiratory or kidney failure, and neurological disease such as Alzheimer's disease, Parkinson's disease and non hepatic metabolic encephalopathies 7. Receiving psychoactive drugs, promotility and hypomotility drugs 8. Hepatocellular carcinoma 9. Electrolyte abnormality (Serum sodium \<125meq/L or serum potassium \<2.5meq/L) 10. Intercurrent infection such as spontaneous bacterial peritonitis 11. Patients of acute on chronic liver failure (ACLF).